EUVIMEDEUVIMED entdecken
Crossref

An effective LC–MS method for the simultaneous determination of a potential anti‐rheumatoid arthritis drug, carboxyamidotriazole, and its major metabolite in rat plasma

Xuli Lang iD, Jia Tang, Yuhui Kou, Chengfeng Xing, Hongfei Mu, Yanan Wang iD, Baolian Wang

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Xuli Lang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Metabolism, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Laboratory of Non-Clinical Drug…. Hauptthemen laut MEDLINE: Triazoles, Rats, Sprague-Dawley, Mass Spectrometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carboxyamidotriazole (CAI) was previously recognized as a well‐tolerated anticancer drug. It has also demonstrated significant anti‐inflammatory effects in various cell and animal model experiments, prompting its investigation as a potential treatment for rheumatoid arthritis. In this study, the potential biotransformation metabolites of CAI were identified both in vitro and in vivo . A sensitive, specific, and accurate LC–MS method was developed for the quantitative analysis of CAI and its major metabolite, CAI‐OH, in rat plasma. CAI, CAI‐OH, and telmisartan (used as an internal standard) were separated using a Zorbax SB C 18 column. The mobile phase consisted of water (phase A, containing 0.1% formic acid) and acetonitrile (phase B, containing 0.1% formic acid) at a flow rate of 0.2 mL/min. The analytes were examined using a high‐resolution mass spectrometer, with detected mass‐to‐charge ratios of m/z 424.01293 for CAI, m/z 440.00785 for CAI‐OH, and m/z 515.24415 for telmisartan. Good linearity was observed within the range of 10–5000 ng/mL. Both inter‐ and intra‐batch precision (relative standard deviation, %) were below 6%, and the accuracy ranged from 94.9% to 106.1%. The analytes remained stable throughout the entire experimental period. This method was successfully applied in a pharmacokinetic study of CAI following oral administration in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesRats, Sprague-DawleyMass SpectrometryAnimalsRatsMaleReproducibility of ResultsChromatography, LiquidLinear ModelsAntirheumatic AgentsLimit of DetectionSensitivity and SpecificityLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

LC–MSanti‐rheumatoid arthritiscarboxyamidotriazole

Substanzen

Triazolescarboxyamido-triazoleAntirheumatic Agents

Autor:innen und Institutionen

  • Department of Drug Metabolism, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Laboratory of Non-Clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Peking Union…
  • Guangdong Yinzhu Pharmaceutical Technology Co., Ltd., Guangzhou, China.

ORCID-Profile: Xuli Lang, Yanan Wang

Förderung

  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Lang, X., Tang, J., Kou, Y., Xing, C., Mu, H., Wang, Y., & Wang, B. (2024). An effective LC–MS method for the simultaneous determination of a potential anti‐rheumatoid arthritis drug, carboxyamidotriazole, and its major metabolite in rat plasma. Biomedical Chromatography. https://doi.org/10.1002/bmc.5923

Vancouver

Lang X, Tang J, Kou Y, Xing C, Mu H, Wang Y, et al. An effective LC–MS method for the simultaneous determination of a potential anti‐rheumatoid arthritis drug, carboxyamidotriazole, and its major metabolite in rat plasma. Biomedical Chromatography. 2024. doi:10.1002/bmc.5923

BibTeX
@article{Lang2024,
  author = {Lang, Xuli and Tang, Jia and Kou, Yuhui and Xing, Chengfeng and Mu, Hongfei and Wang, Yanan and Wang, Baolian},
  title = {An effective LC–MS method for the simultaneous determination of a potential anti‐rheumatoid arthritis drug, carboxyamidotriazole, and its major metabolite in rat plasma},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5923}
}
Kostenlos starten →